Home
About the program
Awards
Essential Info
Submit a Proposal
Contact Us

About the program

In 2012, Bayer launched the Global Ophthalmology Awards Program (GOAP) with the aim of advancing the scientific understanding and clinical management of retinal ophthalmic disorders. Through grants supporting research and training in ophthalmology, the program seeks to provide opportunities for treatment improvement.

 Application Process

Letters of Intent and Full Proposals are reviewed by the Grants Review and Awards Committee (GRAC), which comprises 13 members, representing many of the leading experts from clinical and academic medicine:
  • Dr Jennifer Arnold (Co-Chair)

  • Professor Quan Dong Nguyen (Co-Chair)

  • Professor Francesco Bandello

  • Professor Francine Behar-Cohen

  • Dr Patricia D'Amore

  • Mr Phil Hykin

  • Dr Peter Kertes

  • Dr William Li

  • Professor Masahito Ohji

  • Professor Calvin Pang

  • Professor Daniel Pauleikhoff

  • Dr Francisco Rodríguez

  • Prof. Xiaorong Li

Australia

USA

Italy

France

USA

UK

Canada

USA

Japan

Hong Kong

Germany

Colombia

China

All members of the GRAC will review the Letters of Intent and determine which candidates will be invited to submit full applications. Full Proposals will be reviewed by at least two members of the committee.

Reviewers will evaluate Full Proposals according to the criteria outlined in the Awards section of this website. The reviewers will provide written comments and preliminary numerical scores according to these criteria.

The committee will meet to discuss individual proposals including strengths, weaknesses and scoring. In this meeting, a consensus score for each Full Proposal will be agreed upon. Proposals will then be ranked according to these scores in order to determine funding. In the event of identical scoring, the committee will discuss the proposals in question and revise the scoring in order to clearly define a ranked priority. Funding will occur on a regional basis.

Three regions are defined as:

  1. United States, Canada and Latin America
  2. Europe (for the purposes of this award, the Europe region includes Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom)
  3. Japan, China, India, Australia and all other countries.

Normally, each region will be allocated one Fellowship Project Award and one Research Award. Awards will be determined on the final priority score as agreed by the GRAC. In the event that inadequate numbers of acceptable applications are received from a particular region, additional acceptable proposals will be funded solely on the basis of priority scores, without regard to region.

The committee’s decision is final and there is no appeal mechanism. Applicants who have constructive suggestions about the review of their applications, or the process in general, are encouraged to contact us.

Conflict of Interest

Reviewers will not participate in the review or priority scoring of applications in which they, or institutions with which they are affiliated, have an interest. Also, to the extent practicable, reviewers will not participate in the review of proposals competing for funding with proposals for individuals associated with their institutions.

Confidentiality

The members of the GRAC are bound by the confidentiality rules generally applicable to such bodies.

Want to apply for the Global Ophthalmology Awards Program?
©2018 Bayer. All rights reserved.
General Conditions of Use | Privacy Statement | Imprint
 

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should also be reported to Bayer plc. Tel.: 0118 2063500, Fax.: 0118 2063703, Email: pvuk@bayer.com
If you want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email gb-quality-complaints@bayer.com
For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.